日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intrinsic Factors Influencing Simvastatin and Simvastatin Acid Pharmacokinetics: Age-Related Studies in Thai Adults and Cross-Population Comparisons

影响辛伐他汀和辛伐他汀酸药代动力学的内在因素:泰国成年人年龄相关研究及跨人群比较

Srimatimanon, Thanate; Udomnilobol, Udomsak; Chariyavilaskul, Pajaree; Siwamogsatham, Sarawut; Praditpornsilpa, Kearkiat; Vorasettakarnkij, Yongkasem; Petchlorlian, Aisawan; Vanwong, Natchaya; Piriyapongsa, Jittima; Tipsombatboon, Pavita; Yodsurang, Varalee; Prueksaritanont, Thomayant

Bridging Pharmacokinetics and Pharmacodynamics: A PBPK/PD Model-Based Approach for Deferasirox Dosing in Transfusion-Dependent Thalassemia

连接药代动力学和药效学:基于PBPK/PD模型的去铁酮在输血依赖型地中海贫血患者中的给药策略

Sakares, Watchara; Udomnilobol, Udomsak; Pan, Xian; Yampayon, Kittika; Ekwattanakit, Supachai; Viprakasit, Vip; Limwongse, Chanin; Srichairatanakool, Somdet; Teerawonganan, Polsak; Kunsa-Ngiem, Sumate; Khaowroongrueng, Vipada; Techatanawat, Isariya; Prueksaritanont, Thomayant; Yodsurang, Varalee

Impacts of Pharmacokinetic Gene Polymorphisms on Steady-State Plasma Concentrations of Simvastatin in Thai Population

药代动力学基因多态性对泰国人群辛伐他汀稳态血浆浓度的影响

Tipnoppanon, Sayanit; Udomnilobol, Udomsak; Siwamogsatham, Sarawut; Vorasettakarnkij, Yongkasem; Sukasem, Chonlaphat; Prueksaritanont, Thomayant; Chariyavilaskul, Pajaree; Yodsurang, Varalee; Srimatimanon, Thanate; Chamnanphon, Monpat; Vanwong, Natchaya

Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model

利用综合性的机制性生理药代动力学模型,评估CYP3A和P-gp介导的通路对达比加群酯整体分布和药物相互作用的相对贡献

Udomnilobol, Udomsak; Dunkoksung, Wilasinee; Sakares, Watchara; Jianmongkol, Suree; Prueksaritanont, Thomayant

Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds

吡咯骨架乙型肝炎病毒衣壳抑制剂的结合特性及新型高效化合物的鉴定

Ruengsatra, Tanachote; Meeprasert, Arthitaya; Rattanangkool, Eakkaphon; Deesiri, Sirikan; Srisa, Jakkrit; Udomnilobol, Udomsak; Dunkoksung, Wilasinee; Chuaypen, Natthaya; Kiatbumrung, Rattanaporn; Tangkijvanich, Pisit; Vimolmangkang, Sornkanok; Pudhom, Khanitha; Prueksaritanont, Thomayant

Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach

采用微剂量鸡尾酒疗法定量分析健康青年、健康老年人和慢性肾病老年患者的CYP3A和药物转运体活性

Rattanacheeworn, Punyabhorn; Kerr, Stephen J; Kittanamongkolchai, Wonngarm; Townamchai, Natavudh; Udomkarnjananun, Suwasin; Praditpornsilpa, Kearkiat; Thanusuwannasak, Thanundorn; Udomnilobol, Udomsak; Jianmongkol, Suree; Ongpipattanakul, Boonsri; Prueksaritanont, Thomayant; Avihingsanon, Yingyos; Chariyavilaskul, Pajaree

The effect of the neonatal Fc receptor on human IgG biodistribution in mice

新生儿Fc受体对小鼠人IgG生物分布的影响

Nancy Chen, Weirong Wang, Scott Fauty, Yulin Fang, Lora Hamuro, Azher Hussain, Thomayant Prueksaritanont

Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin

匹伐他汀是一种比瑞舒伐他汀更灵敏、更具选择性的有机阴离子转运多肽1B临床探针。

Prueksaritanont, Thomayant; Chu, Xiaoyan; Evers, Raymond; Klopfer, Stephanie O; Caro, Luzelena; Kothare, Prajakti A; Dempsey, Cynthia; Rasmussen, Scott; Houle, Robert; Chan, Grace; Cai, Xiaoxin; Valesky, Robert; Fraser, Iain P; Stoch, S Aubrey

Drug-drug interaction studies: regulatory guidance and an industry perspective

药物相互作用研究:监管指导和行业视角

Prueksaritanont, Thomayant; Chu, Xiaoyan; Gibson, Christopher; Cui, Donghui; Yee, Ka Lai; Ballard, Jeanine; Cabalu, Tamara; Hochman, Jerome

ADME of biologics-what have we learned from small molecules?

生物制剂的ADME——我们从小分子药物中学到了什么?

Prueksaritanont, Thomayant; Tang, Cuyue